Clinical Trial Update: A Prospective, Open-label, Single-arm Phase II Clinical Study of Fruquintinib Combined With S-1 for the Treatment of Metastatic Colorectal Cancer. [Phase 2]

View source ↗

Summary

This is a prospective, open-label, single-arm Phase II study evaluating Fruquintinib in combination with S-1 for metastatic colorectal cancer; the trial is not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Fruquintinib (fruquintinib)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: Colorectal Cancer | Phase 2 | Status: NOT_YET_RECRUITING